SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-15-000010
Filing Date
2015-01-08
Accepted
2015-01-08 17:02:50
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 OXIS INTERNATIONAL QUARTERLY REPORT oxis10q063014.htm 10-Q 560742
2 CERTIFICATION SECTION 302 ex311.htm EX-31.1 12554
3 CERTIFICATION SECTION 302 ex312.htm EX-31.2 12327
4 CERTIFICATION SECTION 906 ex321.htm EX-32.1 5941
5 CERTIFICATION SECTION 906 ex322.htm EX-32.2 5958
  Complete submission text file 0001513160-15-000010.txt   2733113

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxis-20140630.xml EX-101.INS 313375
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20140630.xsd EX-101.SCH 20138
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oxis-20140630_cal.xml EX-101.CAL 38114
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oxis-20140630_def.xml EX-101.DEF 42777
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oxis-20140630_lab.xml EX-101.LAB 159972
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oxis-20140630_pre.xml EX-101.PRE 119584
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 15516989
SIC: 2834 Pharmaceutical Preparations